Eliscription Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.43 Cr
as on 16-11-2024
- Satisfied Charges ₹ 5.31 Cr
as on 16-11-2024
- Revenue 4.46%
(FY 2023)
- Profit 36.82%
(FY 2023)
- Ebitda 58.63%
(FY 2023)
- Net Worth -271.33%
(FY 2023)
- Total Assets -22.41%
(FY 2023)
About Eliscription
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.43 Cr. The company has closed loans amounting to ₹5.31 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Eliscription Private Limited India is Sri Kasala as CEO. Ramesh Datla, Vanitha Datla, and Sri Kasala serve as directors at the Company.
- CIN/LLPIN
U74900TG2013PTC086622
- Company No.
086622
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Eliscription?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sri Kasala | CEO | 01-Jan-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vanitha Datla  | Director | 26-Mar-2013 | Current |
| Ramesh Datla | Director | 26-Mar-2013 | Current |
Financial Performance and Corporate Structure Insights of Eliscription.
Eliscription Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.46% increase. The company also saw a substantial improvement in profitability, with a 36.82% increase in profit. The company's net worth observed a substantial decline by a decrease of 271.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eliscription?
In 2023, Eliscription had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Elico Healthcare Services LimitedActive 16 years 7 monthsRamesh Datla and Vanitha Datla are mutual person
Elico Mechoptronix Private LimitedActive 5 years 7 monthsRamesh Datla and Vanitha Datla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Mar 2022 | ₹1.43 Cr | Open |
Others Creation Date: 31 Mar 2021 | ₹2.50 Cr | Open |
Others Creation Date: 24 Jun 2020 | ₹2.50 Cr | Open |
How Many Employees Work at Eliscription?
Eliscription has a workforce of 1 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eliscription, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eliscription's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
